GB202007404D0 - Treatment for viral respiratory infections - Google Patents
Treatment for viral respiratory infectionsInfo
- Publication number
- GB202007404D0 GB202007404D0 GBGB2007404.3A GB202007404A GB202007404D0 GB 202007404 D0 GB202007404 D0 GB 202007404D0 GB 202007404 A GB202007404 A GB 202007404A GB 202007404 D0 GB202007404 D0 GB 202007404D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- treatment
- respiratory infections
- viral respiratory
- viral
- infections
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- C07K16/244—Interleukins [IL]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
- C07K14/7155—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for interleukins [IL]
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/52—Assays involving cytokines
- G01N2333/54—Interleukins [IL]
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Virology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cell Biology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Microbiology (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Priority Applications (9)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB2007404.3A GB202007404D0 (en) | 2020-05-19 | 2020-05-19 | Treatment for viral respiratory infections |
JP2022571157A JP2023526853A (ja) | 2020-05-19 | 2021-05-19 | ウイルス性呼吸器感染症の処置 |
PCT/GB2021/051207 WO2021234381A1 (en) | 2020-05-19 | 2021-05-19 | Treatment for viral respiratory infections |
AU2021276614A AU2021276614A1 (en) | 2020-05-19 | 2021-05-19 | Treatment for viral respiratory infections |
US17/999,266 US20230192838A1 (en) | 2020-05-19 | 2021-05-19 | Treatment for viral respiratory infections |
CN202180059606.0A CN116406289A (zh) | 2020-05-19 | 2021-05-19 | 病毒性呼吸道感染的治疗 |
KR1020227044185A KR20230053549A (ko) | 2020-05-19 | 2021-05-19 | 바이러스성 호흡기 감염에 대한 치료 |
EP21729598.9A EP4153302B1 (en) | 2020-05-19 | 2021-05-19 | Treatment for viral respiratory infections |
CA3179461A CA3179461A1 (en) | 2020-05-19 | 2021-05-19 | Treatment for viral respiratory infections |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB2007404.3A GB202007404D0 (en) | 2020-05-19 | 2020-05-19 | Treatment for viral respiratory infections |
Publications (1)
Publication Number | Publication Date |
---|---|
GB202007404D0 true GB202007404D0 (en) | 2020-07-01 |
Family
ID=71135334
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB2007404.3A Ceased GB202007404D0 (en) | 2020-05-19 | 2020-05-19 | Treatment for viral respiratory infections |
Country Status (9)
Country | Link |
---|---|
US (1) | US20230192838A1 (zh) |
EP (1) | EP4153302B1 (zh) |
JP (1) | JP2023526853A (zh) |
KR (1) | KR20230053549A (zh) |
CN (1) | CN116406289A (zh) |
AU (1) | AU2021276614A1 (zh) |
CA (1) | CA3179461A1 (zh) |
GB (1) | GB202007404D0 (zh) |
WO (1) | WO2021234381A1 (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP4179328A2 (en) * | 2020-07-10 | 2023-05-17 | Covid Diagnostics Ltd. | Compositions, methods, and systems for detecting immune response |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK1136556T3 (da) | 1991-11-25 | 2005-10-03 | Enzon Inc | Fremgangsmåde til fremstilling af multivalente antigen-bindende proteiner |
US20040198706A1 (en) | 2003-03-11 | 2004-10-07 | Carrara Dario Norberto R. | Methods and formulations for transdermal or transmucosal application of active agents |
GB0300531D0 (en) | 2003-01-10 | 2003-02-12 | West Pharm Serv Drug Res Ltd | Pharmaceutical compositions |
EP1773403B1 (en) | 2004-07-09 | 2018-04-25 | The University of North Carolina At Chapel Hill | Alphavirus-based adjuvants |
JP5502494B2 (ja) | 2007-01-22 | 2014-05-28 | ターガセプト・インコーポレイテッド | メタニコチンアナログの鼻腔内、バッカル、または舌下投与 |
AU2011347354A1 (en) | 2010-12-20 | 2013-08-01 | Medimmune Limited | Anti-IL-18 antibodies and their uses |
MX2016002719A (es) * | 2013-09-05 | 2016-09-06 | Ab2 Bio Sa | Proteina de union a interleucina 18 (il-18bp) en enfermedades inflamatorias. |
EP3265807A1 (en) | 2015-03-05 | 2018-01-10 | AB2 Bio SA | Il-18 binding protein (il-18bp) and antibodies in inflammatory diseases |
-
2020
- 2020-05-19 GB GBGB2007404.3A patent/GB202007404D0/en not_active Ceased
-
2021
- 2021-05-19 EP EP21729598.9A patent/EP4153302B1/en active Active
- 2021-05-19 US US17/999,266 patent/US20230192838A1/en active Pending
- 2021-05-19 CA CA3179461A patent/CA3179461A1/en active Pending
- 2021-05-19 WO PCT/GB2021/051207 patent/WO2021234381A1/en active Search and Examination
- 2021-05-19 CN CN202180059606.0A patent/CN116406289A/zh active Pending
- 2021-05-19 AU AU2021276614A patent/AU2021276614A1/en active Pending
- 2021-05-19 KR KR1020227044185A patent/KR20230053549A/ko active Search and Examination
- 2021-05-19 JP JP2022571157A patent/JP2023526853A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
AU2021276614A1 (en) | 2023-01-05 |
US20230192838A1 (en) | 2023-06-22 |
CA3179461A1 (en) | 2021-11-25 |
KR20230053549A (ko) | 2023-04-21 |
JP2023526853A (ja) | 2023-06-23 |
EP4153302A1 (en) | 2023-03-29 |
CN116406289A (zh) | 2023-07-07 |
EP4153302B1 (en) | 2024-05-29 |
WO2021234381A1 (en) | 2021-11-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA202006656B (en) | Antiviral immunotropic agent for the treatment of acute respiratory viral infections | |
IL290792A (en) | Preparations and methods for treating viral infections | |
SG11201702766YA (en) | Spiro-indolines for the treatment and prophylaxis of respiratory syncytial virus infection (rsv) | |
GB202007404D0 (en) | Treatment for viral respiratory infections | |
EP4121092C0 (en) | HYBRID INTERFERONS FOR THE TREATMENT OF VIRAL INFECTIONS | |
ZA202212662B (en) | Use of compounds for treating viral infections | |
GB202015584D0 (en) | Treatment for viral infection | |
EP3574089A4 (en) | ANTIVIRAL AGENT AND METHOD OF TREATMENT OF A VIRAL INFECTION | |
PL4021505T3 (pl) | Lek do leczenia chorób zakaźnych | |
IL279078A (en) | Combination therapy for the treatment of hepatitis B viral infection | |
EP3943110C0 (en) | USE OF PHOTOSENSITIZERS TO TREAT VIRAL RESPIRATORY INFECTIONS | |
GB202006160D0 (en) | Treatment of viral infections | |
GB202004998D0 (en) | Treatment of viral infections | |
GB202003232D0 (en) | Treatment of viral infections | |
GB2594617B (en) | Air treatment system | |
GB202315114D0 (en) | Viral treatment | |
AU2021901731A0 (en) | Inhalation formulation for the treatment of respiratory viral infections | |
EP4167989A4 (en) | COMPOSITION FOR THE TREATMENT OF VIRUS INFECTIONS | |
GB202105509D0 (en) | Viral infections | |
GB202020320D0 (en) | Viral infections | |
GB202018571D0 (en) | Viral infections | |
GB202018446D0 (en) | Viral infections | |
GB202013976D0 (en) | Viral infections | |
GB202010271D0 (en) | Viral infections | |
AU2020903062A0 (en) | Treatment for viral infection |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |